CTIS2024-511824-15-00进行中（未招募）1 期
A Phase 1/2 Randomized Trial of BMS-986012 in Combination with Platinum and Etoposide as First-line Therapy in Extensive-Stage Small Cell Lung Cancer - CA001-044
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 1
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- •Pulmonary SCLC documented by histology or cytology, Extensive disease (Stage IV) Small Cell Lung Cancer, Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1, Male and Females 18 years of age or older
排除标准
- •Prior systemic therapy for lung cancer, Symptomatic brain metastases, Grade 2 peripheral neuropathy, Active or chronic infection with human immunodeficiency virus (HIV), hepatitis B virus (HBV), or hepatitis C virus (HCV), Other active malignancies or prior malignancy within 2 years
研究者
相似试验
进行中（未招募）
1 期
A trial of BMS-986012 in combination with chemotherapy for small cell lung cancerMedDRA version: 19.0Level: PTClassification code 10041068Term: Small cell lung cancer extensive stageSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Extensive-Stage Small Cell Lung CancerEUCTR2016-001692-67-ESBristol-Myers Squibb International Corporation160
进行中（未招募）
1 期
A Phase 2 Study of BMS-986315 and Nivolumab in Combination with Chemotherapy in Participants with First-line Stage IV or Recurrent NSCLCCTIS2022-503007-22-00Bristol-Myers Squibb Services Unlimited Company196
已完成
不适用
A Phase 1/2 Multicenter Study of BMS-986012 in Subjects with Relapsed / Refractory Small Cell Lung Cancer (CA001-030)small cell lung cancerneoplasms in the lungNL-OMON43272Bristol-Myers Squibb6
进行中（未招募）
1 期
BMS-986012 in Relapsed/Refractory SCLCMedDRA version: 18.1Level: LLTClassification code 10041071Term: Small cell lung cancer stage unspecifiedSystem Organ Class: 100000004864Small Cell Lung CancerEUCTR2014-002372-89-NLBristol-Myers Squibb International Corporation170
进行中（未招募）
1 期
BMS-986012 in Relapsed/Refractory SCLCMedDRA version: 18.1Level: LLTClassification code 10041071Term: Small cell lung cancer stage unspecifiedSystem Organ Class: 100000004864Small Cell Lung CancerEUCTR2014-002372-89-BEBristol-Myers Squibb International Corporation170